151 related articles for article (PubMed ID: 33023894)
1. Combination Treatment with Sodium Nitrite and Isoquercetin on Endothelial Dysfunction among Patients with CKD: A Randomized Phase 2 Pilot Trial.
Chen J; Hamm LL; Bundy JD; Kumbala DR; Bodana S; Chandra S; Chen CS; Starcke CC; Guo Y; Schaefer CM; Lustigova E; Mahone E; Vadalia AM; Livingston T; Obst K; Hernandez J; Bokhari SR; Kleinpeter M; Alper AB; Lukitsch I; He H; Nieman DC; He J
Clin J Am Soc Nephrol; 2020 Nov; 15(11):1566-1575. PubMed ID: 33023894
[TBL] [Abstract][Full Text] [Related]
2. Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease.
Chen J; Hamm LL; Mohler ER; Hudaihed A; Arora R; Chen CS; Liu Y; Browne G; Mills KT; Kleinpeter MA; Simon EE; Rifai N; Klag MJ; He J
PLoS One; 2015; 10(7):e0132047. PubMed ID: 26132137
[TBL] [Abstract][Full Text] [Related]
3. Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients.
Chitalia N; Ismail T; Tooth L; Boa F; Hampson G; Goldsmith D; Kaski JC; Banerjee D
PLoS One; 2014; 9(3):e91363. PubMed ID: 24646518
[TBL] [Abstract][Full Text] [Related]
4. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
[TBL] [Abstract][Full Text] [Related]
5. Cholecalciferol, Calcitriol, and Vascular Function in CKD: A Randomized, Double-Blind Trial.
Kendrick J; Andrews E; You Z; Moreau K; Nowak KL; Farmer-Bailey H; Seals DR; Chonchol M
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1438-1446. PubMed ID: 28784657
[TBL] [Abstract][Full Text] [Related]
6. Effect of cholesterol lowering treatment on plasma markers of endothelial dysfunction in chronic kidney disease.
Zinellu A; Sotgia S; Mangoni AA; Sotgiu E; Ena S; Satta AE; Carru C
J Pharm Biomed Anal; 2016 Sep; 129():383-388. PubMed ID: 27454090
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of an investigator-initiated, multicenter, prospective open-label, randomized trial to evaluate the effect of ipragliflozin on endothelial dysfunction in type 2 diabetes and chronic kidney disease: the PROCEED trial.
Tanaka A; Shimabukuro M; Okada Y; Sugimoto K; Kurozumi A; Torimoto K; Hirai H; Node K;
Cardiovasc Diabetol; 2020 Jun; 19(1):85. PubMed ID: 32534578
[TBL] [Abstract][Full Text] [Related]
8. Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease.
Thethi TK; Bajwa MA; Ghanim H; Jo C; Weir M; Goldfine AB; Umpierrez G; Desouza C; Dandona P; Fang-Hollingsworth Y; Raghavan V; Fonseca VA
J Diabetes Complications; 2015 Apr; 29(3):433-7. PubMed ID: 25633573
[TBL] [Abstract][Full Text] [Related]
9. Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA
Rosenstock J; Perkovic V; Alexander JH; Cooper ME; Marx N; Pencina MJ; Toto RD; Wanner C; Zinman B; Baanstra D; Pfarr E; Mattheus M; Broedl UC; Woerle HJ; George JT; von Eynatten M; McGuire DK;
Cardiovasc Diabetol; 2018 Mar; 17(1):39. PubMed ID: 29540217
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women.
Blum A; Hathaway L; Mincemoyer R; Schenke WH; Kirby M; Csako G; Waclawiw MA; Panza JA; Cannon RO
J Am Coll Cardiol; 2000 Feb; 35(2):271-6. PubMed ID: 10676669
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines.
Bolton CH; Downs LG; Victory JG; Dwight JF; Tomson CR; Mackness MI; Pinkney JH
Nephrol Dial Transplant; 2001 Jun; 16(6):1189-97. PubMed ID: 11390719
[TBL] [Abstract][Full Text] [Related]
12. Supplementation of the Pure Flavonoids Epicatechin and Quercetin Affects Some Biomarkers of Endothelial Dysfunction and Inflammation in (Pre)Hypertensive Adults: A Randomized Double-Blind, Placebo-Controlled, Crossover Trial.
Dower JI; Geleijnse JM; Gijsbers L; Schalkwijk C; Kromhout D; Hollman PC
J Nutr; 2015 Jul; 145(7):1459-63. PubMed ID: 25972527
[TBL] [Abstract][Full Text] [Related]
13. IL-1 Inhibition and Vascular Function in CKD.
Nowak KL; Chonchol M; Ikizler TA; Farmer-Bailey H; Salas N; Chaudhry R; Wang W; Smits G; Tengesdal I; Dinarello CA; Hung AM
J Am Soc Nephrol; 2017 Mar; 28(3):971-980. PubMed ID: 27647856
[TBL] [Abstract][Full Text] [Related]
14. Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial.
Melamed ML; Horwitz EJ; Dobre MA; Abramowitz MK; Zhang L; Lo Y; Mitch WE; Hostetter TH
Am J Kidney Dis; 2020 Feb; 75(2):225-234. PubMed ID: 31699517
[TBL] [Abstract][Full Text] [Related]
15. ACE-inhibition modulates some endothelial functions in healthy subjects and in normotensive type 1 diabetic patients.
Schalkwijk CG; Smulders RA; Lambert J; Donker AJ; Stehouwer CD
Eur J Clin Invest; 2000 Oct; 30(10):853-60. PubMed ID: 11029598
[TBL] [Abstract][Full Text] [Related]
16. Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD).
Ziedan A; Bhandari S
Trials; 2019 Apr; 20(1):194. PubMed ID: 30947751
[TBL] [Abstract][Full Text] [Related]
17. Effect of spironolactone for 1 yr on endothelial function and vascular inflammation biomarkers in renal transplant recipients.
Mortensen LA; Bistrup C; Stubbe J; Carlström M; Checa A; Wheelock CE; Palarasah Y; Bladbjerg EM; Thiesson HC; Jensen BL
Am J Physiol Renal Physiol; 2019 Sep; 317(3):F529-F539. PubMed ID: 31166706
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial.
de Zeeuw D; Renfurm RW; Bakris G; Rossing P; Perkovic V; Hou FF; Nangaku M; Sharma K; Heerspink HJL; Garcia-Hernandez A; Larsson TE
Lancet Diabetes Endocrinol; 2018 Dec; 6(12):925-933. PubMed ID: 30413396
[TBL] [Abstract][Full Text] [Related]
19. Paricalcitol and endothelial function in chronic kidney disease trial.
Zoccali C; Curatola G; Panuccio V; Tripepi R; Pizzini P; Versace M; Bolignano D; Cutrupi S; Politi R; Tripepi G; Ghiadoni L; Thadhani R; Mallamaci F
Hypertension; 2014 Nov; 64(5):1005-11. PubMed ID: 25259743
[TBL] [Abstract][Full Text] [Related]
20. Effects of sodium nitrite supplementation on vascular function and related small metabolite signatures in middle-aged and older adults.
DeVan AE; Johnson LC; Brooks FA; Evans TD; Justice JN; Cruickshank-Quinn C; Reisdorph N; Bryan NS; McQueen MB; Santos-Parker JR; Chonchol MB; Bassett CJ; Sindler AL; Giordano T; Seals DR
J Appl Physiol (1985); 2016 Feb; 120(4):416-25. PubMed ID: 26607249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
